Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1471 AL 1485

The Associations of Plasma/Serum Carotenoids with Alzheimer's Disease: A Systematic Review and Meta-Analysis

Qu M, Shi H, Wang K, Wang X, Yu N, Guo B.

J Alzheimers Dis. 2021;82(3):1055-1066. doi: 10.3233/JAD-210384.

Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer's Disease: A Meta-Analysis

Xu LZ, Li FY, Li BQ, Cao SM, Li Y, Xu J, Jia JP.

J Alzheimers Dis. 2021;82(3):1357-1367. doi: 10.3233/JAD-210516.

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Cruchaga C, Goate AA, Perrin RJ, Xiong C, Li Y, Morris JC, Snider BJ, Mummery C, Surti GM, Hannequin D, Wallon D, Berman SB, Lah JJ, Jimenez-Velazquez IZ, Roberson ED, van Dyck CH, Honig LS, Sánchez-Valle R, Brooks WS, Gauthier S, Galasko DR, Masters CL, Brosch JR, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Jack CR Jr, Koeppe R, Snyder PJ, Aisen PS, Thomas RG, Berry SM, Wendelberger BA, Andersen SW, Holdridge KC, Mintun MA, Yaari R, Sims JR, Baudler M, Delmar P, Doody RS, Fontoura P, Giacobino C, Kerchner GA, Bateman RJ; Dominantly Inherited Alzheimer Network–Trials Unit.

Nat Med. 2021 Jul;27(7):1187-1196. doi: 10.1038/s41591-021-01369-8. Epub 2021 Jun 21.

Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease

Athar T, Al Balushi K, Khan SA.

Mol Biol Rep. 2021 Jul;48(7):5629-5645. doi: 10.1007/s11033-021-06512-9. Epub 2021 Jun 28.

New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids

Gallo A, Pillet LE, Verpillot R.

Exp Gerontol. 2021 Sep;152:111452. doi: 10.1016/j.exger.2021.111452. Epub 2021 Jun 26.

Cellular Senescence and ApoE4: Their Repercussions in Alzheimer's Disease

Tecalco-Cruz AC, Zepeda-Cervantes J, López-Canovas L, Ramírez-Jarquín JO, Pedraza-Chaverrí J, Briones-Herrera A.

CNS Neurol Disord Drug Targets. 2021;20(9):778-785. doi: 10.2174/1871527320666210628102721.

Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease

Balendra V, Singh SK.

Open Biol. 2021 Jun;11(6):210013. doi: 10.1098/rsob.210013. Epub 2021 Jun 30.

What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?

Gaunitz S, Tjernberg LO, Schedin-Weiss S.

Biomolecules. 2021 Jun 9;11(6):858. doi: 10.3390/biom11060858.

Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer's Disease

Castaneda A, Ferraz R, Vieira M, Cardoso I, Vasconcelos V, Martins R.

Mar Drugs. 2021 Jun 16;19(6):343. doi: 10.3390/md19060343.

Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants

Squitti R, Ventriglia M, Simonelli I, Bonvicini C, Costa A, Perini G, Binetti G, Benussi L, Ghidoni R, Koch G, Borroni B, Albanese A, Sensi SL, Rongioletti M.

Biomolecules. 2021 Jun 29;11(7):960. doi: 10.3390/biom11070960.

The next step of neurogenesis in the context of Alzheimer's disease

Moradi HR, Hajali V, Khaksar Z, Vafaee F, Forouzanfar F, Negah SS.

Mol Biol Rep. 2021 Jul;48(7):5647-5660. doi: 10.1007/s11033-021-06520-9. Epub 2021 Jul 7.

The blood biomarkers puzzle - A review of protein biomarkers in neurodegenerative diseases

Barro C, Zetterberg H.

J Neurosci Methods. 2021 Sep 1;361:109281. doi: 10.1016/j.jneumeth.2021.109281. Epub 2021 Jul 6.

Developing the ATX(N) classification for use across the Alzheimer disease continuum

Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr, Vergallo A.

Nat Rev Neurol. 2021 Sep;17(9):580-589. doi: 10.1038/s41582-021-00520-w. Epub 2021 Jul 8.

Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning

Yuen SC, Liang X, Zhu H, Jia Y, Leung SW.

Alzheimers Res Ther. 2021 Jul 9;13(1):126. doi: 10.1186/s13195-021-00862-z.

Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids

Korecka M, Shaw LM.

J Neurochem. 2021 Oct;159(2):211-233. doi: 10.1111/jnc.15465. Epub 2021 Aug 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias